Five patents currently held, every record listed here
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Mar 2035. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Mar 2035
Next term end
3
Patent families
When these terms end
Each bar runs from grant to computed term end. 2019 to 2037.
US 11,737,916
Magnetic Eye Shields and Methods of Treatment and Diagnosis Using the Same
Mar 5, 2035
US 10,327,945
Magnetic Eye Shields and Methods of Treatment and Diagnosis Using the Same
Nov 24, 2035
US 10,478,332
Magnetic Operating Microscopes and Methods of Treatment and Diagnosis Using the Same
Mar 14, 2037
20232027203120352037
4 pending applications: term is not computable until grant.Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Nov 2035 · Medium confidence
Also notable
Ends Oct 2036 · High confidence
Also notable
Ends Mar 2037 · High confidence
Magnetic Eye Shields and Methods of Treatment and Diagnosis Using the Same
US 10,327,945
The most cited patent in this portfolio, cited by 11 later US patents, top 25% of utility patents granted in 2019 in our data. Protection runs to 2035.
Identification and Isolation of Human Corneal Endothelial Cells (HCECS)
US 10,655,102
The newest of the three, granted 2020. It anchors the portfolio to 2036, later than anything else here.
Magnetic Operating Microscopes and Methods of Treatment and Diagnosis Using the Same
US 10,478,332
The earliest of the three still in force, granted 2019 and renewed since. Its term ends first, in 2037.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 25, 2026The maintenance fee for Magnetic Eye Shields and Methods of Treatment and Diagnosis Using the Same (US 10,327,945) comes due Dec 25, 2026. Unpaid by Jun 25, 2027, it lapses early.
- 2 fees due Feb 28, 2027
- 1 fee due May 19, 2027The maintenance fee for Magnetic Operating Microscopes and Methods of Treatment and Diagnosis Using the Same (US 10,478,332) comes due May 19, 2027. Unpaid by Nov 19, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
| Identification and Isolation of Human Corneal Endothelial Cells (HCECS) | 2 in force | to Oct 2036 |
| Magnetic Eye Shields and Methods of Treatment and Diagnosis Using the Same | 2 in force | to Nov 2035 |
| Magnetic Operating Microscopes and Methods of Treatment and Diagnosis Using the Same | 1 in force | to Mar 2037 |
Patents held now
Soonest term end first.
Showing 1 to 5 of 5
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,737,916 | Magnetic Eye Shields and Methods of Treatment and Diagnosis Using the Same In force · Medium confidence | In force | Medium confidence | |
| US 11,740,239 | Identification and Isolation of Human Corneal Endothelial Cells (HCECS) In force · High confidence | In force | High confidence | |
| US 10,327,945 | Magnetic Eye Shields and Methods of Treatment and Diagnosis Using the Same In force · Medium confidence | In force | Medium confidence | |
| US 10,655,102 | Identification and Isolation of Human Corneal Endothelial Cells (HCECS) In force · High confidence | In force | High confidence | |
| US 10,478,332 | Magnetic Operating Microscopes and Methods of Treatment and Diagnosis Using the Same In force · High confidence | In force | High confidence |
Also on record, not counted in the 5: 4 applications pending. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.